Skip to main content
Ashok Leyland Ltd. logo

Ashok Leyland Ltd. — Investor Relations & Filings

Ticker · ASHOKLEY ISIN · INE208A01029 LEI · 3358001BZKWERVWYCK35 BSE.NS Manufacturing
Open in API
Filings indexed 2,793 across all filing types
Latest filing 2025-08-08 Regulatory Filings
Country IN India
Listing BSE.NS ASHOKLEY

About Ashok Leyland Ltd.

https://www.ashokleyland.com/

Ashok Leyland Ltd. is a prominent manufacturer of commercial vehicles, specializing in the design and production of medium and heavy commercial vehicles, light commercial vehicles, and passenger transportation solutions. The company's product portfolio includes a diverse range of trucks, buses, and specialized vehicles for defense and industrial applications. Key offerings include the AVTR modular truck platform, the Dost and Bada Dost series of light commercial vehicles, and bus models ranging from 18 to 80 seaters. Beyond vehicle assembly, the company produces high-performance engines for marine and industrial use and provides comprehensive aftermarket support through spare parts and service networks. Serving global markets, it caters to sectors such as logistics, construction, and public transit. The company is distinguished by its engineering expertise in modular vehicle architecture and its position as a major supplier of logistics vehicles to armed forces.

Recent filings

Filing Released Lang Actions
Secretarial Audit Report of Hinduja Leyland Finance Limited, Material Subsidiary of the Company
Regulatory Filings
2025-08-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter to stock exchanges about the schedule of a conference call for analysts and investors. It references a conference call to discuss financial results for the quarter ended June 30, 2025, but does not contain any financial data or results itself. It is a notification about the timing and logistics of the call, not the call transcript or financial report. The document length is short (3062 characters) and it serves as an announcement of the conference call schedule. Therefore, it fits the category of a Call Transcript announcement or schedule notice, but since it is not the transcript itself, the best fitting category is Regulatory Filings (RNS) as a general announcement. However, given the specific nature of the document as a conference call schedule notice, the closest specific category is Call Transcript (CT) as it relates directly to the call, but since it is only the schedule and not the transcript, the fallback is Regulatory Filings (RNS). According to the rules, announcements about calls are generally classified as Regulatory Filings (RNS) unless the full transcript is provided. Hence, the classification is RNS with high confidence.
2025-08-06 English
Analyst /Investor Meet - August 14, 2025
Call Transcript Classification · 90% confidence The document is an intimation letter to stock exchanges about the schedule of a conference call for analysts and investors. It references a conference call to discuss the financial results for the quarter ended June 30, 2025, but does not contain any financial data or results itself. The document is short (3062 characters) and serves as a notification of the call schedule rather than the call transcript or financial report. Therefore, it is best classified as a Call Transcript (CT) related announcement, but since it is only the schedule notice and not the transcript, it fits the category of a Call Transcript (CT) type document as it pertains to the conference call event. Confidence is high due to clear mention of conference call schedule and participants without actual transcript content.
2025-08-06 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-08-04 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying about a scheduled Board Meeting to approve the standalone and consolidated un-audited financial results for the quarter ended June 30, 2025. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to board meeting disclosures. The document does not contain the financial results themselves but is an announcement of the upcoming approval of these results. The document length is short (1813 characters) and it serves as a notification rather than the actual financial report or earnings release. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than an Interim Report (IR) or Earnings Release (ER).
2025-08-04 English
Ashok Leyland Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve the un-audited results for the ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying about a scheduled Board Meeting to approve the standalone and consolidated un-audited financial results for the quarter ended June 30, 2025. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to board meeting disclosures. The document does not contain the financial results themselves but is an announcement of the upcoming approval of those results. The document length is short (1813 characters), and it serves as a notification rather than the actual financial report or earnings release. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about the board meeting and financial results approval, not the results themselves or a detailed report.
2025-08-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.